What is STRATA Skin Sciences?
STRATA Skin Sciences operates as a specialized medical technology enterprise focused on the dermatology sector. The company is primarily engaged in the development, commercialization, and marketing of proprietary in-office treatment systems, most notably its XTRAC and Pharos excimer lasers, alongside the VTRAC lamp systems. These technologies are engineered to address chronic dermatologic conditions, including psoriasis and vitiligo, positioning the company as a critical provider of clinical-grade therapeutic hardware for dermatologists globally. By integrating advanced light-based technology into clinical workflows, STRATA Skin Sciences bridges the gap between complex medical engineering and patient-centric dermatological care.
How much funding has STRATA Skin Sciences raised?
STRATA Skin Sciences has raised a total of $245.8M across 17 funding rounds:
Stock Offering
$16.3M
Stock Offering
$7.3M
Stock Offering
$6M
Debt
$12.4M
Other Financing Round
$27.3M
Debt
$10M
Private Equity
$17M
Debt
$2M
Debt
$7M
Stock Issuance/Offering (2011): $16.3M featuring Undisclosed
Stock Issuance/Offering (2013): $7.3M backed by Undisclosed
Stock Issuance/Offering (2013): $6M with participation from Undisclosed
Debt (2014): $12.5M led by Sabby Management
Other Financing Round (2014): $27.3M supported by Sabby Management, Great Point Partners, and Broadfin Capital
Debt (2016): $10M featuring MidCap Financial Trust
Private Equity (2018): $17M backed by Broadfin Capital, Sabby Management, Accelmed Growth Partners, and Dr. Dolev Rafeli
Debt (2020): $2M with participation from PPP
Debt (2023): $7M led by MidCap Financial
Key Investors in STRATA Skin Sciences
MidCap Financial
MidCap Financial provides flexible, asset-based financing solutions tailored to the needs of growing companies, focusing on efficient capital deployment to support operational objectives.
Great Point Partners
Great Point Partners is a prominent healthcare-focused investment firm that provides growth equity and recapitalization to companies across the biopharmaceutical and medical device sectors.
Broadfin Capital
Broadfin Capital is a specialized healthcare investment firm that manages unique opportunities for accredited investors, focusing on strategic asset allocation within the medical and life sciences industries.
What's next for STRATA Skin Sciences?
Looking ahead, the infusion of capital from recent financing rounds is expected to accelerate the company's strategic initiatives in product innovation and market penetration. Given the current lifecycle stage, which reflects a mature enterprise-level focus, the organization is likely to prioritize the expansion of its installed base and the optimization of its recurring revenue models. By leveraging its established technological foundation, STRATA Skin Sciences is well-positioned to capitalize on the growing demand for non-invasive, high-efficacy dermatological treatments, ensuring long-term value creation for stakeholders while maintaining its leadership in the specialized medical device market.
See full STRATA Skin Sciences company page
